Jewell Christopher M — SEC Form 4 filings
SEC reporting owner CIK 2000226. 6 Form 4 filings on record with FilingPulse; latest filed 2025-01-13.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-04-10 to 2025-01-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 54,665 shares, $917,825 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 18,550 shares @ $16.34 ($303,126) in Cartesian Therapeutics, Inc., filed 2024-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | Chief Scientific Officer | 6 | — | 5 legs · 54,665 sh · $917,825 | 12 |
Form 4 filings — Jewell Christopher M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-13 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 9,000 @ $3.23 · Option exercise (M): 9,000 (derivative) | EDGAR |
| 2025-01-07 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Sale (S): 1,264 @ $16.72 · Sale (S): 1,286 @ $16.83 | EDGAR |
| 2025-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 16,100 @ $0 · Grant/award (A): 47,400 (derivative) @ $0 | EDGAR |
| 2024-11-21 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 14,000 @ $3.23 · Option exercise (M): 14,000 (derivative) | EDGAR |
| 2024-11-18 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 36,050 @ $3.23 · Sale (S): 18,550 @ $16.34 · Sale (S): 17,500 @ $17.02 · Option exercise (M): 16,065 @ $3.23 · Sale (S): 16,065 @ $17.06 · Option exercise (M): 36,050 (derivative) · +1 more | EDGAR |
| 2024-04-10 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 4,276.45 (derivative) · Option exercise (M): 142,547 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2000226 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →